Osimertinib mesylate CAS: 1421373-66-1
| Product Parameters | |
|---|---|
| Catalog No. | BA1E02 |
| CAS.RN | 1421373-66-1 |
| Molecular Formula | C29H37N7O5S |
| Molecular Weight | 595.71 g/mol |
| Purity | NLT 98% |
| Synonyms | AZD-9291 |
Product Overview
Osimertinib mesylate (CAS 1421373-66-1) is an API product that may be used in pharmaceutical R&D, intermediate synthesis, process development, and quality research. Specific applications, specifications, and suitability should be confirmed according to project requirements.
Quality & Supply Capability
English Name : Osimertinib mesylate
Supply Capability : Samples, gram scale, kilogram scale, and commercial batches
Packaging : Foil bags, fluorinated bottles, fiber drums, and custom packaging
Document Support : COA, MSDS, HPLC/GC, NMR, and other documents
Bioncan can provide sample supply, lab-scale preparation, pilot scale-up, and customized batch production for Osimertinib mesylate (CAS 1421373-66-1) according to customer project requirements. We can offer flexible supply plans based on purity, impurity control, packaging, delivery schedule, and quality documentation requirements. For Raw Materials and related projects, we provide technical support from laboratory research to scale-up production to help customers advance process development, route optimization, and project transfer.
Why Choose Bioncan
Bioncan is a manufacturer and supplier of Raw Materials-related products, with support for an API product. For Osimertinib mesylate (CAS 1421373-66-1), we can support sample requests, bulk production supply, custom synthesis communication, route optimization, specification confirmation, and project scale-up.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1421373-66-1, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
